Michael E. Laska
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- Viral gastroenteritis research and epidemiology
- Immunology top 10%
- Immunotherapy and Immune Responses
Papers in
-
- Viral gastroenteritis research and epidemiology 3
-
- Viral Infectious Diseases and Gene Expression in Insects 3
- Advanced biosensing and bioanalysis techniques 1
- Co-authors
- Mike Smith (3 shared papers)James D. Thompson (2 shared papers)Giuseppe Ciaramella (2 shared papers)Örn Almarsson (2 shared papers)Michael Watson (2 shared papers)Tal Zaks (2 shared papers)Alex Bulychev (2 shared papers)Joseph J. Senn (2 shared papers)
- Journals
- Human Gene Therapy (2 papers)Molecular Therapy (1 paper)Veterinary Pathology (1 paper)Biotechnology and Bioengineering (1 paper)Vaccine (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Michael E. Laska
7 papers receiving 996 citations
Michael E. Laska's Hit Papers
Peers
Comparison fields: 5 of 74
- Infectious Diseases 428
- Immunology 288
- Animal Science and Zoology 118
- Molecular Biology 704
- Genetics 187
Countries citing papers authored by Michael E. Laska
This map shows the geographic impact of Michael E. Laska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Laska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Laska more than expected).
Fields of papers citing papers by Michael E. Laska
This network shows the impact of papers produced by Michael E. Laska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Laska. The network helps show where Michael E. Laska may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael E. Laska, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses Hit paper breakdown → | 2017 | 493 |
| 2 | mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials Hit paper breakdown → | 2019 | 331 |
| 3 | 2017 | 148 | |
| 4 | 2005 | 35 | |
| 5 | 2005 | 32 | |
| 6 | 2005 | 1 | |
| 7 | 2021 | 1 |
About Michael E. Laska
Michael E. Laska is a scholar working on Infectious Diseases, Molecular Biology, Genetics, Oncology and Epidemiology, having authored 7 papers that have together received 1.0k indexed citations. Recurring topics across this work include Viral Infectious Diseases and Gene Expression in Insects (3 papers), Viral gastroenteritis research and epidemiology (3 papers), Virus-based gene therapy research (3 papers), Influenza Virus Research Studies (2 papers), Advanced biosensing and bioanalysis techniques (1 paper), CAR-T cell therapy research (1 paper), PARP inhibition in cancer therapy (1 paper) and Membrane Separation Technologies (1 paper). The work is most often cited by research in Infectious Diseases (428 citations), Immunology (288 citations), Animal Science and Zoology (118 citations), Molecular Biology (704 citations) and Genetics (187 citations). Michael E. Laska has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Mike Smith, James D. Thompson, Giuseppe Ciaramella, Örn Almarsson, Michael Watson, Tal Zaks, Alex Bulychev, Joseph J. Senn, Luis A. Brito and Olga Yuzhakov. Their work appears in journals such as Human Gene Therapy, Molecular Therapy, Veterinary Pathology, Biotechnology and Bioengineering and Vaccine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.